Skip to main content

Table 2 follow up scheme

From: Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial

Timepoint

Study period

Pre-treatment

Study treatment

Follow-up

Enrolment

RT planning

RT start (wk 1)

RT end (wk 2)

wk 6

wk 12

6 mths after RT

9 mths after RT

12 mths after RT

15 mths after RT

18 mths after RT

21 mths after RT

24 mths after RT

30 mths after RT

36 mths after RT

42 mths after RT

48 mths after RT

54 mths after RT

60 mths after RT

In case of recurrence

Eligibility screen

x

                   

Informed consent

x

                   

Medical history

x

 

x

x

x

x

x

x

x

 

x

 

x

 

x

   

x

x

Symptoms

x

 

x

 

x

x

x

x

x

 

x

 

x

 

x

   

x

x

PSA level*

x

   

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

x

MR Linac simulation

x

                   

Toxicity

  

x

x

x

x

x

x

x

 

x

 

x

 

x

   

x

x

CT pelvis

 

x

                  

MRI pelvis**

 

x

                  

EORTC QoL questionnaires

x

  

x

x

x

x

x

x

 

x

 

x

 

x

   

x

x

Blood test

x

                   
  1. *PSA can be tested at treating urologist or at study center (according to local standard operating procedures)
  2. **Optional